NO922807L - Farmasoeytiske dideoksypurinnukleosid-preparater til oraltbruk - Google Patents
Farmasoeytiske dideoksypurinnukleosid-preparater til oraltbrukInfo
- Publication number
- NO922807L NO922807L NO92922807A NO922807A NO922807L NO 922807 L NO922807 L NO 922807L NO 92922807 A NO92922807 A NO 92922807A NO 922807 A NO922807 A NO 922807A NO 922807 L NO922807 L NO 922807L
- Authority
- NO
- Norway
- Prior art keywords
- reduced mass
- didexypurin
- nucleoside
- preparations
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/12—Magnesium silicate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US73354791A | 1991-07-22 | 1991-07-22 | |
US88220492A | 1992-05-13 | 1992-05-13 |
Publications (3)
Publication Number | Publication Date |
---|---|
NO922807D0 NO922807D0 (no) | 1992-07-16 |
NO922807L true NO922807L (no) | 1993-01-25 |
NO300198B1 NO300198B1 (no) | 1997-04-28 |
Family
ID=27112590
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO922807A NO300198B1 (no) | 1991-07-22 | 1992-07-16 | Farmasöytisk dideoksypurinnukleosid-preparat for oral administrering |
Country Status (23)
Country | Link |
---|---|
US (1) | US5880106A (no) |
EP (1) | EP0524579B1 (no) |
JP (1) | JP3038456B2 (no) |
KR (1) | KR960011772B1 (no) |
CN (1) | CN1042299C (no) |
AT (1) | ATE163855T1 (no) |
AU (1) | AU657337B2 (no) |
CA (1) | CA2074215C (no) |
DE (1) | DE69224684T2 (no) |
DK (1) | DK0524579T3 (no) |
ES (1) | ES2113389T3 (no) |
FI (1) | FI105153B (no) |
GR (1) | GR3026332T3 (no) |
HU (3) | HU9202318D0 (no) |
IE (1) | IE922365A1 (no) |
IL (1) | IL102519A (no) |
MX (1) | MX9204256A (no) |
NO (1) | NO300198B1 (no) |
NZ (1) | NZ243567A (no) |
PL (1) | PL295329A1 (no) |
RU (1) | RU2089193C1 (no) |
TW (1) | TW211521B (no) |
ZA (1) | ZA925484B (no) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA69413C2 (uk) * | 1998-05-22 | 2004-09-15 | Брістол-Майерс Сквібб Компані | Фармацевтична композиція, яка містить серцевину та ентеросолюбільну оболонку, фармацевтична композиція у вигляді сфероїдальних гранул, спосіб одержання сфероїдальних гранул та спосіб одержання фармацевтичної композиції |
US7122207B2 (en) * | 1998-05-22 | 2006-10-17 | Bristol-Myers Squibb Company | High drug load acid labile pharmaceutical composition |
AU764370B2 (en) * | 1998-06-18 | 2003-08-14 | George Washington University, The | Methods of administering camptothecin compounds for the treatment of cancer with reduced side effects |
UA73092C2 (uk) * | 1998-07-17 | 2005-06-15 | Брістол-Майерс Сквібб Компані | Таблетка з ентеросолюбільним покриттям і спосіб її приготування |
US6174873B1 (en) * | 1998-11-04 | 2001-01-16 | Supergen, Inc. | Oral administration of adenosine analogs |
US20040028772A1 (en) * | 2000-08-14 | 2004-02-12 | Carsten Andersen | Method for preparation of chewing gum with customer acceptable taste |
US6887926B1 (en) | 2001-11-16 | 2005-05-03 | Oatey Co. | Bonding compositions for chlorinated polymers and methods of using the same |
CN100415211C (zh) * | 2003-07-03 | 2008-09-03 | 上海现代药物制剂工程研究中心 | 抗艾滋病药去羟肌苷的肠溶微粒组合物及制备方法 |
US20080299227A1 (en) * | 2007-05-30 | 2008-12-04 | Sunhealth Therapies, Inc. | Method for removal of HIV from the gastrointestinal tract and bile of HIV-infected subjects and for the prevention of drug failure and prevention of development of AIDS in HIV-infected subjects |
US8173621B2 (en) | 2008-06-11 | 2012-05-08 | Gilead Pharmasset Llc | Nucleoside cyclicphosphates |
US8716263B2 (en) | 2008-12-23 | 2014-05-06 | Gilead Pharmasset Llc | Synthesis of purine nucleosides |
US8551973B2 (en) | 2008-12-23 | 2013-10-08 | Gilead Pharmasset Llc | Nucleoside analogs |
EP3222628A1 (en) | 2008-12-23 | 2017-09-27 | Gilead Pharmasset LLC | Nucleoside phosphoramidates |
TWI576352B (zh) | 2009-05-20 | 2017-04-01 | 基利法瑪席特有限責任公司 | 核苷磷醯胺 |
UY33312A (es) | 2010-03-31 | 2011-10-31 | Pharmasset Inc | Fosforamidato de nucleosido de purina |
PT3290428T (pt) | 2010-03-31 | 2021-12-27 | Gilead Pharmasset Llc | Comprimido compreendendo 2-(((s)-(((2r,3r,4r,5r)-5-(2,4-dioxo-3,4-dihidropirimidin-1-(2h)-il)¿4¿fluoro¿3¿hidroxi¿4¿metiltetrahidrofuran¿2¿il)metoxi) (fenoxi)fosforil)amino)propanoato de (s)- isopropil cristalino |
PL3290428T3 (pl) | 2010-03-31 | 2022-02-07 | Gilead Pharmasset Llc | Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu |
EP2428201A1 (en) | 2010-09-08 | 2012-03-14 | Merck Serono S.A. | Oral administration of nucleoside monophosphates |
AU2011336632B2 (en) | 2010-11-30 | 2015-09-03 | Gilead Pharmasset Llc | Compounds |
CN102949406B (zh) * | 2011-08-31 | 2014-03-12 | 天津药物研究院 | 一种复方艾夫他滨药物组合物及其制备方法和用途 |
AR089857A1 (es) * | 2012-02-02 | 2014-09-24 | Glaxosmithkline Llc | Comprimido antiacido para refrescar el aliento |
WO2014078435A1 (en) | 2012-11-14 | 2014-05-22 | W. R. Grace & Co.-Conn. | Compositions containing a biologically active material and a non-ordered inorganic oxide |
CN104069126A (zh) * | 2014-07-02 | 2014-10-01 | 浙江康乐药业股份有限公司 | 一种治疗胃酸过多的药物及其制备方法 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4260596A (en) * | 1979-08-13 | 1981-04-07 | Bristol-Myers Company | Edible unit dosage form consisting of outer mannitol shell and inner liquid or gel center and method for manufacturing the same |
US4339428A (en) * | 1980-08-18 | 1982-07-13 | Bristol-Myers Company | Capsule product containing high dosage of aspirin in powder or granulated form and alkaline tablet or pellet comprising magnesium carbonate, calcium carbonate and a magnesium dry component |
CA1239349A (en) * | 1983-10-10 | 1988-07-19 | Eberhard F. Gottwald | Pharmaceutical composition containing cimetidine |
WO1987001284A1 (en) * | 1985-08-26 | 1987-03-12 | United States Of America, Represented By The Unite | Inhibition of in vitro infectivity and cytopathic effect of htlv-iii/lav by 2',3'-dideoxynosine, 2',3'-dideoxyguanosine, or 2',3'-dideoxyadenosine |
GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
US4921707A (en) * | 1986-06-24 | 1990-05-01 | Istvan Racz | Proceeding for the production of pharmaceutical preparations of high gastric acid binding capacity, of retarded effect and of increased bioavailability |
WO1988002629A1 (en) * | 1986-10-16 | 1988-04-21 | American Health Products Corporation | 2',3'-didesoxyadenosine composition |
US4935243A (en) * | 1988-12-19 | 1990-06-19 | Pharmacaps, Inc. | Chewable, edible soft gelatin capsule |
US5026687A (en) * | 1990-01-03 | 1991-06-25 | The United States Of America As Represented By The Department Of Health And Human Services | Treatment of human retroviral infections with 2',3'-dideoxyinosine alone and in combination with other antiviral compounds |
-
1992
- 1992-07-15 NZ NZ243567A patent/NZ243567A/en unknown
- 1992-07-15 HU HU9202318A patent/HU9202318D0/hu unknown
- 1992-07-16 JP JP4231248A patent/JP3038456B2/ja not_active Expired - Lifetime
- 1992-07-16 TW TW081105639A patent/TW211521B/zh not_active IP Right Cessation
- 1992-07-16 NO NO922807A patent/NO300198B1/no not_active IP Right Cessation
- 1992-07-16 IL IL10251992A patent/IL102519A/en not_active IP Right Cessation
- 1992-07-17 PL PL29532992A patent/PL295329A1/xx unknown
- 1992-07-20 EP EP92112371A patent/EP0524579B1/en not_active Expired - Lifetime
- 1992-07-20 AU AU20396/92A patent/AU657337B2/en not_active Expired
- 1992-07-20 ES ES92112371T patent/ES2113389T3/es not_active Expired - Lifetime
- 1992-07-20 FI FI923308A patent/FI105153B/fi not_active IP Right Cessation
- 1992-07-20 CA CA002074215A patent/CA2074215C/en not_active Expired - Fee Related
- 1992-07-20 DE DE69224684T patent/DE69224684T2/de not_active Expired - Lifetime
- 1992-07-20 DK DK92112371.7T patent/DK0524579T3/da active
- 1992-07-20 AT AT92112371T patent/ATE163855T1/de active
- 1992-07-21 HU HU9202375A patent/HU220612B1/hu unknown
- 1992-07-21 CN CN92108657A patent/CN1042299C/zh not_active Expired - Lifetime
- 1992-07-21 ZA ZA925484A patent/ZA925484B/xx unknown
- 1992-07-21 RU SU925052174A patent/RU2089193C1/ru active
- 1992-07-21 KR KR1019920012989A patent/KR960011772B1/ko not_active IP Right Cessation
- 1992-07-21 IE IE236592A patent/IE922365A1/en not_active IP Right Cessation
- 1992-07-21 MX MX9204256A patent/MX9204256A/es unknown
-
1995
- 1995-06-20 HU HU95P/P00275P patent/HU211285A9/hu unknown
-
1997
- 1997-10-02 US US08/942,660 patent/US5880106A/en not_active Expired - Lifetime
-
1998
- 1998-03-12 GR GR970402511T patent/GR3026332T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO922807L (no) | Farmasoeytiske dideoksypurinnukleosid-preparater til oraltbruk | |
IT1211484B (it) | Forma farmaceutica di dosaggio per somministrazione orale con erogazione controllata di un ingrediente attivo | |
PT90466A (pt) | Processo de preparacao de composicoes farmaceuticas compreendendo um excipiente extragranular, higroscopio insoluvel em agua e um ingrediente activo, em particular a cimetidina | |
ATE125155T1 (de) | Niedrigdosierte getrocknete pharmazeutische präparate. | |
ATE158504T1 (de) | Brausemischungen enthaltend ibuprofen und verfahren | |
DE69211688D1 (de) | Kaubare antacida | |
GB2282758A (en) | Oral morphine-6-glucuronide compositions | |
TH13351A (th) | สารประกอบ | |
ITRM910038A1 (it) | Composizioni farmaceutiche aventi come principio attivo calcitonina da somministrarsi per via intranasale. | |
TH63EX (th) | เครื่องแยกจำพวกด้วยวิธีโฟโทอิเล็คทริกสำหรับอุปกรณ์แยกจำพวกสี |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |